
The discovery of immune checkpoint inhibitors (ICIs) revolutionized the treatment of advanced melanoma, however, there is currently no easy way to predict patient response or their risk for immune-related toxicities without conducting RNA sequencing – a method rarely found at community oncology clinics. Researchers report an emerging technique that aims to solve this problem by …
Continue reading “AI Model Predicts Immunotherapy Response in Melanoma Patients”